Literature DB >> 28688786

Perception of Barriers to the Diagnosis and Receipt of Treatment for Neuropsychiatric Disturbances After Traumatic Brain Injury.

Jennifer S Albrecht1, Lyndsay M O'Hara2, Kara A Moser2, C Daniel Mullins3, Vani Rao4.   

Abstract

OBJECTIVE: To explore perceptions of barriers and facilitators to the diagnosis and receipt of treatment for neuropsychiatric disturbances (NPDs) after traumatic brain injury (TBI).
DESIGN: Qualitative study using semistructured interviews and focus groups.
SETTING: A clinic specializing in the treatment of TBI NPDs, an urban trauma center, and a large urban academic hospital. PARTICIPANTS: A sample (N=33) of health care providers (n=10) who treat individuals with TBI, persons with TBI (n=18), and caregivers (n=5).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Topic guides for the interviews and focus groups were guided by previous literature, clinical experience, and the goals of the project and focused on the 3 most common TBI NPDs: depression, anxiety, and posttraumatic stress disorder. The interviews and focus groups were audio-recorded and transcribed verbatim. We performed a conventional content analysis on the transcripts and grouped concepts into overall themes, incorporating feedback from stakeholders.
RESULTS: Patient education, insurance, provider type, time since TBI, caregiver support, and recognition or screening for TBI NPDs were the most frequently mentioned barriers or facilitators to the diagnosis and treatment of TBI NPDs by both interview and focus group participants. We grouped these and other frequently mentioned concepts into 3 broad themes: education, access, and support. Each of these themes is explored in depth and supported with direct quotations.
CONCLUSIONS: This study explored patient, caregiver, and health care provider and identified barriers and facilitators to the diagnosis and receipt of treatment for TBI NPDs. Barriers included poor provider education on TBI NPDs and limited access to care due to lack of insurance, transportation, and income. Facilitators included patient education on TBI NPDs and strong caregiver support. Future studies should develop and pilot interventions aimed at quality of care that address the identified barriers and facilitators.
Copyright © 2017 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain injury; Mental disorders; Rehabilitation

Mesh:

Year:  2017        PMID: 28688786      PMCID: PMC6935532          DOI: 10.1016/j.apmr.2017.06.007

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  25 in total

Review 1.  Traumatic brain injury: a disease process, not an event.

Authors:  Brent E Masel; Douglas S DeWitt
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

2.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

3.  Acceptance of insurance by psychiatrists and the implications for access to mental health care.

Authors:  Tara F Bishop; Matthew J Press; Salomeh Keyhani; Harold Alan Pincus
Journal:  JAMA Psychiatry       Date:  2014-02       Impact factor: 21.596

4.  Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury.

Authors:  Deborah L Warden; Barry Gordon; Thomas W McAllister; Jonathan M Silver; Jeffery T Barth; John Bruns; Angela Drake; Tony Gentry; Andy Jagoda; Douglas I Katz; Jess Kraus; Lawrence A Labbate; Laurie M Ryan; Molly B Sparling; Beverly Walters; John Whyte; Ashley Zapata; George Zitnay
Journal:  J Neurotrauma       Date:  2006-10       Impact factor: 5.269

5.  The impact of major depression on outcome following mild-to-moderate traumatic brain injury in older adults.

Authors:  Mark J Rapoport; Alexander Kiss; Anthony Feinstein
Journal:  J Affect Disord       Date:  2006-02-28       Impact factor: 4.839

6.  Predicting depression following mild traumatic brain injury.

Authors:  Harvey S Levin; Stephen R McCauley; Claudia Pedroza Josic; Corwin Boake; Sharon A Brown; Heather S Goodman; Shirley G Merritt; Susan I Brundage
Journal:  Arch Gen Psychiatry       Date:  2005-05

7.  Rate of psychiatric illness 1 year after traumatic brain injury.

Authors:  S Deb; I Lyons; C Koutzoukis; I Ali; G McCarthy
Journal:  Am J Psychiatry       Date:  1999-03       Impact factor: 18.112

8.  Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury.

Authors:  Jennifer S Albrecht; Zippora Kiptanui; Yuen Tsang; Bilal Khokhar; Gordon S Smith; Ilene H Zuckerman; Linda Simoni-Wastila
Journal:  J Neurotrauma       Date:  2015-03-25       Impact factor: 5.269

9.  Psychiatric disorders following traumatic brain injury: their nature and frequency.

Authors:  Rochelle Whelan-Goodinson; Jennie Ponsford; Lisa Johnston; Fiona Grant
Journal:  J Head Trauma Rehabil       Date:  2009 Sep-Oct       Impact factor: 2.710

10.  The psychiatric sequelae of traumatic injury.

Authors:  Richard A Bryant; Meaghan L O'Donnell; Mark Creamer; Alexander C McFarlane; C Richard Clark; Derrick Silove
Journal:  Am J Psychiatry       Date:  2010-01-04       Impact factor: 18.112

View more
  3 in total

1.  Safety of Antidepressant Classes Used Following Traumatic Brain Injury Among Medicare Beneficiaries: A Retrospective Cohort Study.

Authors:  Jennifer S Albrecht; Vani Rao; Eleanor M Perfetto; C Daniel Mullins
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

2.  A systematic review on integrated care for traumatic brain injury, mental health, and substance use.

Authors:  Vincy Chan; Danielle Toccalino; Samira Omar; Riya Shah; Angela Colantonio
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

3.  Social determinants of health associated with psychological distress stratified by lifetime traumatic brain injury status and sex: Cross-sectional evidence from a population sample of adults in Ontario, Canada.

Authors:  Vincy Chan; Lauren Marcus; Danielle Burlie; Robert E Mann; Danielle Toccalino; Michael D Cusimano; Gabriela Ilie; Angela Colantonio
Journal:  PLoS One       Date:  2022-08-31       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.